The future of metered-dose inhalers

Pharmaceutical Technology Europe

Volumn 17, Issue 9, 2005, Pages 22-31

  Pritchard, John ^a  

^a 3M Drug Delivery Systems   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVAIR DISKUS; BECLOMETASONE DIPROPIONATE; CHLOROFLUOROCARBON; FLOVENT DISKUS; FLOVENT ROTADISK; FLUORINATED HYDROCARBON; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL FUMARATE; IPRATROPIUM BROMIDE; LEVALBUTEROL; SALBUTAMOL; TIOTROPIUM BROMIDE;

ARTICLE; CORRELATION ANALYSIS; DEVICE; DRUG APPROVAL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG MANUFACTURE; DRUG MARKETING; DRY POWDER; HUMAN; MEDICAL TECHNOLOGY; METERED DOSE INHALER; ROOM TEMPERATURE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 24944510514     PISSN: 01646826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. M.J. Molina and F.S. Rowlands, Nature 249, 810-812 (1974).
2. J.C. Farman, B.G. Gardiner and J.D. Shanklin, Nature 315, 207-210 (1985).
3. The Management Forum, Manuf Chem. July, 22-23 (1992).
4. Committee for Proprietary Medicinal Products, "Results of the co-ordinated review of 1,1,1,2-tetrafluroethane HFC-134a," European Comission, Brussels (1994).
5. J.N. Pritchard, "Recent advances in drug delivery via pressurised metered-dose inhalers," in L. Gradon and J. Marijinissen, Eds., Optimization of Aerosol Drug Delivery (Kluwer Academic, Dordrech, The Netherlands, 2003) pp 105-122.
6. J.S. Stefely et al., "Equipping the MDI for the 21st century by expanding its formulation options," in R.N. Dalby et al,. Eds, Respiratory Drug Delivery VII (Serentec Press Inc., Raleigh, NC, USA, 2000) pp 82-90.
7. I. Tansey, Brit. J. Clin. Pract. 89 (Suppl), 22-27 (1997).
8. R.J Warby, European Patent Application No. 1208864 (2002).
9. M. Wilby, Drug Del. Sys. Sci. (in press).
10. D. Tiwari et al., Drug Dev. Ind. Pharm. 24, 345-352 (1998).
11. L. Bradley, K. Hunt and T. Fenn, "The performance of the EPDM Spraymiser valve," Drug Delivery to the Lungs XV (The Aerosol Society, Portishead, UK 2004) pp 101-104.
12. D. Howlett and J. Colwell, "Improvements in extractables from pMDI elastomer Systems," Drug Delivery to the Lungs VIII (The Aerosol Society, Portishead, UK, 1997) pp 36-38.
13. A. Clark, J. Biopharm. Sci. 3, 69-76 (1992).
14. B.J. Gabrio, S.W. Stein and D.J. Velasquez, Int. J. Pharm. 186, 3-12 (1999).
15. P. Jinks, "The use of expert system software to improve the efficiency of the inhalation product development process," Drug Delivery to the Lungs XV (The Aerosol Society, Portishead, UK, 2004) pp 107-110.
16. J.N. Pritchard, "Accelerating drug development," Drug Delivery to the Lungs XV (The Aerosol Society, Portishead, UK, 2004) pp 84-87.
17. J. Moore et al., in R.N Dalby et al., Eds, Respiratory Drug Delivery IX (Davis Healthcare International Publishing, River Grove, IL, USA, 2004).
18. www.imshealth.com